Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/10/2025

Differential Diagnosis for Progressive Proximal Muscle Weakness Following Prolonged Corticosteroid Use

Primary Differential Diagnoses

  • The low-normal CPK with proximal muscle weakness pattern strongly suggests steroid myopathy rather than inflammatory myopathy, which typically presents with elevated CPK, according to the Mayo Clinic Proceedings 1
  • The absence of muscle enzyme elevation with EMG showing normal findings further supports non-inflammatory myopathy, as stated by the Mayo Clinic Proceedings 1
  • Despite negative antibodies, seronegative inflammatory myopathy remains possible as autoantibodies are absent in 20-30% of cases, according to the Mayo Clinic Proceedings 1
  • The normal EMG/NCS strongly argues against active inflammatory myopathy, as EMG in polymyositis typically shows polyphasic motor unit action potentials of short duration and low amplitude with fibrillation potentials, as stated by the Mayo Clinic Proceedings 1 and the Journal of Clinical Oncology 3
  • Muscle biopsy would be definitive but was not performed; this remains the gold standard for confirming inflammatory myopathy with characteristic mononuclear cell infiltration, according to the Mayo Clinic Proceedings 1

Diagnostic Considerations

  • The American Academy of Neurology recommends obtaining muscle biopsy of affected proximal muscle to definitively distinguish inflammatory myopathy from muscular dystrophy 1
  • The American College of Rheumatology suggests requesting immunohistochemistry for dysferlin, dystrophin, and inflammatory markers, as well as Gomori trichrome stain to evaluate for ragged red fibers, according to the Mayo Clinic Proceedings 1 and Praxis Medical Insights 2
  • Repeat MRI of proximal muscles with STIR sequences to assess for muscle edema/inflammation is recommended, as active inflammatory myositis shows T2 hyperintensity and edema, according to the Mayo Clinic Proceedings 1 and Praxis Medical Insights 2

Monitoring Parameters

  • Serial CPK and aldolase measurements off steroids are recommended, as rising levels would suggest inflammatory or dystrophic process rather than steroid myopathy, according to Praxis Medical Insights 2 and 5
  • Pulmonary function testing with negative inspiratory force and vital capacity is suggested, given respiratory muscle symptoms, according to the Journal of Clinical Oncology 3
  • Cardiac evaluation with troponin, ECG, and echocardiogram to exclude cardiac involvement seen in inflammatory myopathies and some muscular dystrophies is recommended, according to the Journal of Clinical Oncology 3 and Praxis Medical Insights 5